Stem cell differentiation and organ maintenance is controlled by lipid metabolism
Researchers from the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena combined the use of mouse pluripotent stem cells and flatworms to identify genes that control lifelong maintenance and regeneration of tissues. Flatworms (also known as planarians) possess immortal regenerative capacity. Now it was discovered that the induction of fat metabolism by the Tnfaip2 gene promotes the ability of stem cells to produce differentiated organ cells. When the gene is lost, planarians lose their capacity of organ maintenance and regeneration. Disturbances in fat metabolism may also contribute to the loss of organ maintenance and to cancer development at old age.
The planarian Schmidtea mediterranea consists of 25% stem cells and are almost immortal. They can maintain their organs forever by regenerating completely and not ageing in the process.
FLI / Anna Schroll
Jena. Fat metabolism (lipid metabolism) is the term used to describe the synthesis and degradation of lipids in cells. This is increasingly recognized as an important key process that could also influence the maintenance and differentiation of stem cells. It has already been shown that fat metabolism is important for the maintenance of stem cells in the blood.
It is assumed that intermediates of fat metabolism, the so-called lipid metabolites, contribute to the differentiation of stem cells. Stem cell differentiation is essential to produce new organ cells (e.g. skin, blood and nerve cells). Yet, it is not yet well understood, which genetic factors contribute to stem cell differentiation by controlling lipid metabolism. This could be of fundamental importance in understanding how changes in fat metabolism lead to disease development, e.g. loss of organ maintenance during ageing or the development of cancer.
Researchers from the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena, together with colleagues from the Friedrich Schiller University Jena (FSU), have studied the differentiation of pluripotent stem cells. These results have now been published in the scientific journal "EMBO Reports". "Stem cells are extremely important for the permanent renewal of organs and tissue. Through these differentiation processes, new specialized stem cells are constantly created in the body where they are needed," reports Prof. K. Lenhard Rudolph, group leader at the FLI and Professor of Molecular Medicine at the FSU. "This process is controlled by genes. The extent to which genes control stem cell function via a control of lipid metabolism is currently not sufficiently known."
The gene Tnfaip2 controls stem cell differentiation
For the genetic screen, the researchers reprogrammed mouse fibroblasts into induced pluripotent stem cells (iPS cells) in cell culture. Using this method, they were able to identify Tnfaip2 as a new gene that crucially enhances the transition of somatic cells into iPS cells. "Our study showed that Tnfaip2 centrally controls the differentiation of stem cells; if it is switched off, the reprogramming of mouse fibroblasts into iPS cells is enhanced," explains Dr. Sarmistha Deb, first author and former PhD student at the FLI. In order to be able to investigate the function and influence on the differentiation ability of stem cells under real conditions, i.e. in a living organism (in vivo), the researchers used planarians (flatworms) as a model organism of immortal capacity to maintain and regenerate organs.
Regulation of stem cell differentiation and regeneration in planarians
The planarian, flatworm Schmidtea mediterranea also possesses a Tnfaip2-like gene (Smed-exoc3). Planarians consist of 25% stem cells. They are found in the fountains of our inner cities, among other places, and can maintain and regenerate their organs forever, without any signs of losing this capacity during ageing. The experiments with the planarians were supervised by Dr Cristina González-Estévez, an expert in the field of research on the immortality of Schmidtea mediterranea.
"We thought that we could use the immortal planarian model system to identify genes that are also necessary to maintain stem cell function in mammals," Dr González-Estévez explains the approach in the study. "The results were astonishing. The down-regulation of the gene Tnfaip2-like in planarians led to a decreased capacity of the stem cells to produce differentiated organ cells. The ability to regenerate and maintain organs was completely abolished due to the loss of a single gene".
Stem cell differentiation and organ maintenance is controlled by lipid metabolism
And that’s not all, the research team was able to prove that Tnfaip2 controls stem cell function by controlling fat metabolism. When the worms with the missing gene function were given fatty acids and fatty acid transporters (e.g. palmitoyl-L-carnitine), stem cell differentiation resumed. The organs could be maintained without the function of the Tnfaip2 gene orthologue.
"With our new discovery pipeline using pluripotent cell screens followed by functional analysis of the target genes in planarians, we can speed up the discovery of genes that are important for stem cell maintenance and function", Prof. Rudolph emphasizes the results. "This will allow us to identify gene functions that are important for stem cell function in mammals or humans. We would like to use this knowledge to clarify unknown causes for the loss of organ maintenance and the development of diseases during ageing".
Original publication
Sarmistha Deb, Daniel A. Felix, Philipp Koch, Maharshi Krishna Deb, Karol Szafranski, Katrin Buder, Mara Sannai, Marco Groth, Joanna Kirkpatrick, Stefan Pietsch, André Gollowitzer, Alexander Groß, Philip Riemenschneider, Andreas Koeberle, Cristina González-Estévez, K. Lenhard Rudolph; "Tnfaip2/exoc3-driven lipid metabolism is essential for stem cell differentiation and organ homeostasis"; EMBO Rep (2020), e49328.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
